Evidence map›Paper›PMID 32155995›Full record

ArticleInternational journal of molecular sciences2020

Clinical Significance of Cytoplasmic IgE-Positive Mast Cells in Eosinophilic Chronic Rhinosinusitis.

Yuka Gion, Mitsuhiro Okano, Takahisa Koyama, Tokie Oura, Asami Nishikori, Yorihisa Orita, Tomoyasu Tachibana, Hidenori Marunaka, Takuma Makino, Kazunori Nishizaki and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Phenotypic and Functional Diversity of Mast Cells.International journal of molecular sciences · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yuka GionDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, Japan.
Mitsuhiro OkanoDepartment of Otolaryngology of Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan..
Takahisa KoyamaDepartment of Otolaryngology of Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan..
Tokie OuraDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, Japan.
Asami NishikoriDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, Japan.
Yorihisa OritaDepartment of Otolaryngology, Head and Neck Surgery, Kumamoto University Graduate School, Kumamoto 860-8556, Japan.
Tomoyasu TachibanaDepartment of Otolaryngology, Japanese Red Cross Society Himeji Hospital, Himeji 670-8540, Japan.ORCID 0000-0002-2909-4069
Hidenori MarunakaDepartment of Otolaryngology of Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan..
Takuma MakinoDepartment of Otolaryngology of Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan..ORCID 0000-0002-8727-9846
Kazunori NishizakiDepartment of Otolaryngology of Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan..
Yasuharu SatoDivision of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama 700-8558, Japan.ORCID 0000-0001-5234-6861
Okayama University · JPHimeji Red Cross Hospital · JPKumamoto University · JP

Funding

Japan Society for the Promotion of Science 19K16586
6 · The paper itself

Abstract

Cross-linking of antigen-specific IgE bound to the high-affinity IgE receptor (FcεRI) on the surface of mast cells with multivalent antigens results in the release of mediators and development of type 2 inflammation. FcεRI expression and IgE synthesis are, therefore, critical for type 2 inflammatory disease development. In an attempt to clarify the relationship between eosinophilic chronic rhinosinusitis (ECRS) and mast cell infiltration, we analyzed mast cell infiltration at lesion sites and determined its clinical significance. Mast cells are positive for c-kit, and IgE in uncinated tissues (UT) and nasal polyps (NP) were examined by immunohistochemistry. The number of positive cells and clinicopathological factors were analyzed. Patients with ECRS exhibited high levels of total IgE serum levels and elevated peripheral blood eosinophil ratios. As a result, the number of mast cells with membranes positive for c-kit and IgE increased significantly in lesions forming NP. Therefore, we classified IgE-positive mast cells into two groups: membrane IgE-positive cells and cytoplasmic IgE-positive cells. The amount of membrane IgE-positive mast cells was significantly increased in moderate ECRS. A positive correlation was found between the membrane IgE-positive cells and the radiological severity score, the ratio of eosinophils, and the total serum IgE level. The number of cytoplasmic IgE-positive mast cells was significantly increased in moderate and severe ECRS. A positive correlation was observed between the cytoplasmic IgE-positive cells and the radiological severity score, the ratio of eosinophils in the blood, and the total IgE level. These results suggest that the process of mast cell internalization of antigens via the IgE receptor is involved in ECRS pathogenesis.

Indexed as

AdultAgedAged, 80 and overCell MovementEosinophiliaEosinophilsFemaleHumansImmunoglobulin EMaleMast CellsMiddle AgedNasal PolypsProto-Oncogene Proteins c-kitRhinitisSinusitisImmunoglobulin EKIT protein, humanProto-Oncogene Proteins c-kitc-kiteosinophilic chronic rhinosinusitisIgEmast cell

Identifiers

PMID32155995
PMCPMC7084524
OpenAlexW3010121424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.